Mondrian Investment Partners Limited (Mondrian) recently trimmed their stake in HK-listed MicroPort Scientific Corporation (MicroPort). According to a filing submitted to the Hong Kong Stock Exchange on August 4th, 2017, Mondrian sold 738,600 shares on the exchange at an average price of HKD 6.7056 per share on August 3rd (total consideration was ~US$635,000). Following the sale, their stake in MicroPort decreased from 6.02% to 5.97% of the company’s shares outstanding.

MicroPort is a Hong Kong-based investment holding company principally engaged in both the manufacture and sale of medical products. The company operates across a number of major medical disciplines including cardiovascular, orthopaedic, endovascular, neurovascular, diabetes and endocrine management. MicroPort was founded in 1998 by Dr. Zhaohua Chang.

Mondrian is an independent, employee-owned, global value-oriented investment manager with offices in London and Philadelphia. The firm has ~US$61bn in assets under management.